Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Cryoconservation of Peptide Extracts From Trypsin Digestion of Proteins for Proteomic Analysis in a Hospital Biobank Facility

  • Mateos, Jesús
  • Pintor-Iglesias, Alejandra
  • Fernández-Puente, Patricia
  • García-Camba, Marta
  • Ruiz-Romero, Cristina
  • Doménech, Nieves
  • Blanco García, Francisco J
This document is the Accepted Manuscript version of a Published Article that appeared in final form in Journal of Proteome Research, copyright © 2014 American Chemical Society. To access the final published article, see ACS Articles on Request., [Abstract] We tested a semiautomated protocol for the proper storage and conservation in a hospital biobank of tryptic peptide extracts coming from samples with low and high protein complexity for subsequent mass spectrometry analysis. Low-complexity samples (serum albumin, serotransferrin. and alpha-S1-casein) were loaded in replicates in SDS-PAGE and subjected to standard in-gel trypsin digestion. For LC-MALDI-TOF/TOF analysis, purified β-galactosidase and human serum samples were in-solution digested following standard procedures and desalted with C18 stage-tips. In both cases, peptides extracts were aliquoted in individually 2D coded tubes, vacuum-dried, barcode-read, and stored in an automated -20 °C freezer in the Biobank facility. Samples were kept dried at -20 °C until the corresponding time-point of analysis, then reconstituted in the proper buffer and analyzed by either MALDI-TOF/TOF (peptide fingerprinting and MS/MS) or LC-MALDI-TOF/TOF following a highly reproducible pattern to ensure the reproducibility of the results. Protein identification was done with either Mascot or Protein Pilot as search engines using constant parameters. Over a period of 1 year we checked six different time points at days 0, 7, 30, 90, 180, and 365. We compared MS and MS/MS protein score, number of identified peptides, and coverage of the identified proteins. In the low complexity samples, the number of peptides detected gradually decreased over time, especially affecting the MS score. However, two of the three proteins - serum albumin and serotransferrin - were identified by both PMF and MS/MS at day 90. By day 180, only MS/MS identification in some replicates was possible. By LC-MS/MS, β-galactosidase and the most abundant serum proteins were identified with good scores at all time points even by day 365, with no detectable peptide loss or decrease in the fragmentation efficiency, although a progressive decrease in peptide intensity indicates that detection of low abundant proteins could not be optimal after very long periods of time. Our results encourage us to use the biobank facility in the future for long-term storage - up to 3 months - of dried peptide extracts., This study was funded by grants from Fondo Investigacion Sanitaria-Spain (CP09/00114, PI11/02397, PI12/00329) and Secretaria I+D+I Xunta de Galicia (10CSA916058PR). J.M. (CA11/00050) and P.F.-P. (CA09/00458) are supported by Fondo Investigacion Sanitaria-Spain. C.R.-R. is supported by the Miguel Servet program from Fondo Investigacion Sanitaria-Spain (CP09/00114). This study is integrated into the chromosome 16 Spanish Human Proteome Project. ProteoRed is part of the Biomolecular and Bioinformatics Resources Platform, PRB2-ISCIII, supported by grant (ISCIII, PT13/0001 from the Carlos III National Health Institute).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Mass spectrometry imaging: A novel technology in rheumatology

  • Rocha Loureda, Beatriz
  • Ruiz-Romero, Cristina
  • Blanco García, Francisco J
Review, [Abstract] Mass spectrometry imaging (MSI) is used to determine the relative abundance and spatial distribution of biomolecules such as peptides, proteins, lipids and other organic compounds in tissue sections by their molecular masses. This technique provides a sensitive and label-free approach for high-resolution imaging, and is currently used in an increasing number of biomedical applications such as biomarker discovery, tissue classification and drug monitoring. Owing to technological advances in the past 5 years in diverse MSI strategies, this technology is expected to become a standard tool in clinical practice and provides information complementary to that obtained using existing methods. Given that MSI is able to extract mass-spectral signatures from pathological tissue samples, this technique provides a novel platform to study joint-related tissues affected by rheumatic diseases. In rheumatology, MSI has been performed on articular cartilage, synovium and bone to increase the understanding of articular destruction and to characterize diagnostic and prognostic biomarkers for osteoarthritis, rheumatoid arthritis and osteoporosis. In this Review, we provide an overview of MSI technology and of the studies in which joint tissues have been analysed by use of this methodology. This approach might increase knowledge of rheumatic pathologies and ultimately prompt the development of targeted strategies for their management., This work is funded by grants from Fondo Investigación Sanitaria-Spain (PI12/00329, PI14/01707, CIBER‑CB06/01/0040, RETICRIER‑RD12/0009/0018). B.R. is funded by Xunta de Galicia (IN606B‑2016/004), and C.R.R. by the Miguel Servet II program from Fondo Investigación Sanitaria-Spain (CPII15/0013). The Proteomics Unit belongs to ProteoRed, PRB2‑ISCIII, supported by grant PT13/0001.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Screening and validation of novel biomarkers in osteoarticular pathologies by comprehensive combination of protein array technologies

  • Sierra-Sánchez, Álvaro
  • Garrido-Martín, Diego
  • Lourido, Lucía
  • González-González, María
  • Díez, Paula
  • Ruiz-Romero, Cristina
  • Sjöberg, Ronald
  • Droste, Conrad
  • De Las Rivas, Javier
  • Nilsson, Peter
  • Blanco García, Francisco J
  • Fuentes, Manuel
[Abstract] Osteoarthritis (OA) is one of the most prevalent articular diseases. The identification of proteins closely associated with the diagnosis, progression, prognosis, and treatment response is dramatically required for this pathology. In this work, differential serum protein profiles have been identified in OA and rheumatoid arthritis (RA) by antibody arrays containing 151 antibodies against 121 antigens in a cohort of 36 samples. Then the identified differential serum protein profiles have been validated in a larger cohort of 282 samples. The overall immunoreactivity is higher in the pathological situations in comparison with the controls. Several proteins have been identified as biomarker candidates for OA and RA. Most of these biomarker candidates are proteins related to inflammatory response, lipid metabolism, or bone and extracellular matrix formation, degradation, or remodeling., We gratefully acknowledge financial support from the Carlos III Health Institute of Spain (ISCIII, FIS PI14/01538, PI12/00624, PI12/00329, PI14/01707, CIBER-CB06/01/0040, and RETIC-RIER-RD12/0009/0018), Fondos FEDER (EU), Junta Castilla y León (BIO/SA07/15), and Fundación Solórzano (FS-23-2015). The Proteomics Unit belongs to ProteoRed, PRB2-ISCIII, supported by Grant No. PT13/0001 (ISCIII-Fondos FEDER). P.D. and C.D. are supported by a JCYL-EDU/346/2013 Ph.D. scholarship. The work of D.G.M. was supported by a collaboration scholarship (BOE-A-2014-3844) from the Spanish Ministry of Education, Culture, and Sports (MECD) and awarded in the XIII Certamen Universitario Arquímedes (BOE-A-2014-12688, MECD). We also thank Javier Martín Vallejo and Manuel Muñoz Aguirre for useful discussions and statistical support.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Biochemical Evidence for Gap Junctions and CX43 Expression in Immortalized Human Chondrocyte Cell Line: A Potential Model in the Study of Cell Communication in Human Chondrocytes

  • Gago-Fuentes, Raquel
  • Carpintero-Fernández, Paula
  • Goldring, Mary Brennan
  • Brink, Peter R.
  • Mayán, María D.
  • Blanco García, Francisco J
Brief report, [Abstract] Objective: The development of chondrocytic cell lines has enabled the investigation of the role of cellular phenotype and mechanisms in articular cartilage biology and physiopathology of several rheumatic diseases. Among them, the T/C-28a2 cell line has become a common tool in cartilage research. Recent results from our group have revealed that primary human chondrocytes in tissue and in monolayer culture contain high levels of connexin 43 (Cx43) and are able to directly communicate through gap junction (GJ) channels. These results challenge the existing thesis of cartilage physiology, that chondrocytes do not have the capacity to physically communicate with each other. Established cell lines offer the advantage of convenience and uniformity; however, the establishment process may cause a disruption of GJ. This study was performed to investigate if T/C-28a2 cells contain Cx43 protein and form functional channels. Methods: Cx43 was characterized by RT-qPCR, Western blotting, and immunohistochemistry (IHC). Electrophysiology experiments, Lucifer Yellow (LY) uptake, electroporation in situ and scrape loading assay were performed to test the functionality of GJs. Results: T/C-28a2 cells express Cx43. Electrophysiology experiments and LY uptake confirmed the capacity of these cells to communicate through GJ channels, although these cells contain significant levels of active c-Src kinase, presumably due to their immortalization with the Simian Virus 40 large T antigen. The results were validated using primary chondrocytes (PC). Conclusions: These results reveal that the T/C-28a2 line may provide a useful in vitro model for the study of Cx43 function and cell communication to understand the physiology of chondrocytes and cartilage., This work was supported in part through funding from the Fondo Investigación Sanitaria, Madrid, Spain (CIBER – CB06/01/0040; PI12/00329; RETIC-RIER-RD12/0009/0018; Proteo-Red/ISCIII) (to FJB); Ministerio Ciencia e Innovación PLE2009-0144, FEDER (European Community) (to FJB); Sociedad Española de Reumatología (FER 2013) (to MDM) and ISCIII (PI13/00591) (to MDM); National Institutes of Health grants RO1 GM088180 (to PRB) and R01-AG022021 (to MBG); a pre-doctoral fellowship from Xunta de Galicia to Raquel Gago-Fuentes. María D Mayán is an Isidro Parga Pondal researcher (Xunta de Galicia).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Lessons from the proteomic study of osteoarthritis

  • Ruiz-Romero, Cristina
  • Fernández-Puente, Patricia
  • Calamia, Valentina
  • Blanco García, Francisco J
Review, [Abstract] Osteoarthritis is the most common rheumatic pathology and one of the leading causes of disability worldwide. It is a very complex disease whose etiopathogenesis is not fully understood. Furthermore, there are serious limitations for its management, since it lacks specific and sensitive biomarkers for early diagnosis, prognosis and therapeutic monitoring. Proteomic approaches performed in the last few decades have contributed to the knowledge on the molecular mechanisms that participate in this pathology and they have also led to interesting panels of putative biomarker candidates. In the next few years, further efforts should be made for translating these findings into the clinical routines. It is expected that targeted proteomics strategies will be highly valuable for the verification and qualification of biomarkers of osteoarthritis., This work is funded by grants from Fondo Investigación Sanitaria-Spain (PI11/02397, PI12/00329 and PI14/01707). C. Ruiz-Romero is supported by the Miguel Servet program from Fondo Investigación Sanitaria, Spain (CP09/00114).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Articular chondrocyte network mediated by gap junctions: Role in metabolic cartilage homeostasis

  • Mayán, María D.
  • Gago-Fuentes, Raquel
  • Carpintero-Fernández, Paula
  • Fernández-Puente, Patricia
  • Filgueira-Fernández, P.
  • Goyanes, Noa
  • Valiunas, Virginijus
  • Brink, Peter R.
  • Goldberg, Gary S.
  • Blanco García, Francisco J
Extended report, [Abstract] Objective: This study investigated whether chondrocytes within the cartilage matrix have the capacity to communicate through intercellular connections mediated by voltage-gated gap junction (GJ) channels. Methods: Frozen cartilage samples were used for immunofluorescence and immunohistochemistry assays. Samples were embedded in cacodylate buffer before dehydration for scanning electron microscopy. Co-immunoprecipitation experiments and mass spectrometry (MS) were performed to identify proteins that interact with the C-terminal end of Cx43. GJ communication was studied through in situ electroporation, electrophysiology and dye injection experiments. A transwell layered culture system and MS were used to identify and quantify transferred amino acids. Results: Microscopic images revealed the presence of multiple cellular projections connecting chondrocytes within the matrix. These projections were between 5 and 150 µm in length. MS data analysis indicated that the C-terminus of Cx43 interacts with several cytoskeletal proteins implicated in Cx trafficking and GJ assembly, including α-tubulin and β-tubulin, actin, and vinculin. Electrophysiology experiments demonstrated that 12-mer oligonucleotides could be transferred between chondrocytes within 12 min after injection. Glucose was homogeneously distributed within 22 and 35 min. No transfer was detected when glucose was electroporated into A549 cells, which have no GJs. Transwell layered culture systems coupled with MS analysis revealed connexins can mediate the transfer of L-lysine and L-arginine between chondrocytes. Conclusions: This study reveals that intercellular connections between chondrocytes contain GJs that play a key role in cell-cell communication and a metabolic function by exchange of nutrients including glucose and essential amino acids. A three-dimensional cellular network mediated through GJs might mediate metabolic and physiological homeostasis to maintain cartilage tissue., This work was supported in part through funding from the Fondo Investigación Sanitaria, Madrid, Spain (CIBER-CB06/01/0040; PI12/00329; RETIC-RIER-RD12/0009/0018; and Proteo-Red/ISCIII) (to FJB); Ministerio Ciencia e Innovación PLE2009-0144, FEDER (European Community) (to FJB); and the National Institutes of Health grants R01 GM088181 (to VV) and PRB-NIH RO1 GM088180 (to PRB). This work was also supported through funding from a CIBBER-BNN fellowship, a predoctoral fellowship from Xunta de Galicia to RG-F and a grant from Fondo Investigación Sanitaria-Spain (CA09/00458) to PF-P. MDM is an Isidro Parga Pondal researcher (Xunta de Galicia).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis

  • Fernández-Puente, Patricia
  • Calamia, Valentina
  • González-Rodríguez, Lucía
  • Lourido, Lucía
  • Camacho Encina, María
  • Oreiro Villar, Natividad
  • Ruiz-Romero, Cristina
  • Blanco García, Francisco J
[Abstract] The methods currently available for the diagnosis and monitoring of osteoarthritis (OA) are very limited and lack sensitivity. Being the most prevalent rheumatic disease, one of the most disabling pathologies worldwide and currently untreatable, there is a considerable interest pointed in the verification of specific biological markers for improving its diagnosis and disease progression studies. Considering the remarkable development of targeted proteomics methodologies in the frame of the Human Proteome Project, the aim of this work was to develop and apply a MRM-based method for the multiplexed analysis of a panel of 6 biomarker candidates for OA encoded by the Chromosome 16, and another 8 proteins identified in previous shotgun studies as related with this pathology, in specimens derived from the human joint and serum. The method, targeting 35 different peptides, was applied to samples from human articular chondrocytes, healthy and osteoarthritic cartilage, synovial fluid and serum. Subsequently, a verification analysis of the biomarker value of these proteins was performed by single point measurements on a set of 116 serum samples, leading to the identification of increased amounts of Haptoglobin and von Willebrand Factor in OA patients. Altogether, the present work provides a tool for the multiplexed monitoring of 14 biomarker candidates for OA, and verifies for the first time the increased amount of two of these circulating markers in patients diagnosed with this disease. Significance: We have developed an MRM method for the identification and relative quantification of a panel of 14 protein biomarker candidates for osteoarthritis. This method has been applied to analyze human articular chondrocytes, articular cartilage, synovial fluid, and finally a collection of 116 serum samples from healthy controls and patients suffering different degrees of osteoarthritis, in order to verify the biomarker usefulness of the candidates. HPT and VWF were validated as increased in OA patients., This work was funded by grants from Fondo Investigación Sanitaria-Spain (PI12/00329, PI14/01707, CIBER-CB06/01/0040, RETIC-RIER-RD12/0009/0018). C.R.-R. is supported by the Miguel Servet II program from Fondo Investigación Sanitaria-Spain (CPII15/00013). The Proteomics Unit belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Osteoarthritis Year in Review 2014: We Need More Biochemical Biomarkers in Qualification Phase

  • Blanco García, Francisco J
Review, [Abstract] The current diagnosis of osteoarthritis (OA) relies on the description of pain symptoms, affected joint stiffness, and radiography used as the reference technique for determining the grade of joint destruction. Limitations of the presently available diagnostic tests have provided an impetus for the substantial increase in interest in finding new specific biological markers for cartilage degradation to facilitate the early diagnosis of joint destruction, evaluate disease progression and improve disease prognosis. Biomarkers for OA are also useful for drug development, treatment monitoring, and as a basis for personalized evidence-based action plans. This review summarizes 29 manuscripts published during 2013 with a focus on soluble biochemical biomarkers, primarily those utilizing proteomic, metabolomics, lipidomic and imaging mass spectrometry technologies., This work was supported in part through funding from the Fondo Investigación Sanitaria, Madrid, Spain (CIBER- CB06/01/0040; PI12/00329; RETIC-RIER-RD12/0009/0018 and Proteo-Red/ISCIII); and Red Gallega REDICENT.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

MALDI mass spectrometry imaging in rheumatic diseases

  • Rocha Loureda, Beatriz
  • Cillero-Pastor, B.
  • Blanco García, Francisco J
  • Ruiz-Romero, Cristina
Review, [Abstract] Mass spectrometry imaging (MSI) is a technique used to visualize the spatial distribution of biomolecules such as peptides, proteins, lipids or other organic compounds by their molecular masses. Among the different MSI strategies, MALDI-MSI provides a sensitive and label-free approach for imaging of a wide variety of protein or peptide biomarkers from the surface of tissue sections, being currently used in an increasing number of biomedical applications such as biomarker discovery and tissue classification. In the field of rheumatology, MALDI-MSI has been applied to date for the analysis of joint tissues such as synovial membrane or cartilage. This review summarizes the studies and key achievements obtained using MALDI-MSI to increase understanding on rheumatic pathologies and to describe potential diagnostic or prognostic biomarkers of these diseases. This article is part of a Special Issue entitled: MALDI Imaging, edited by Dr. Corinna Henkel and Prof. Peter Hoffmann., This work was funded by grants from Fondo Investigación Sanitaria-Spain (PI12/00329, PI14/01707, CIBER-CB06/01/0040, RETIC-RIER-RD12/0009/0018). C.R.-R. is supported by the Miguel Servet II program from Fondo Investigación Sanitaria-Spain (CPII15/00013). The Proteomics Unit belongs to ProteoRed, PRB2- ISCIII, supported by grant PT13/0001.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Analysis of Autoantibody Profiles in Osteoarthritis Using Comprehensive Protein Array Concepts

  • Henjes, Frauke
  • Lourido, Lucía
  • Ruiz-Romero, Cristina
  • Fernández-Tajes, Juan
  • Schwenk, Jochen M.
  • González-González, María
  • Blanco García, Francisco J
  • Nilsson, Peter
  • Fuentes, Manuel
[Abstract] Osteoarthritis (OA) is the most common rheumatic disease and one of the most disabling pathologies worldwide. To date, the diagnostic methods of OA are very limited, and there are no available medications capable of halting its characteristic cartilage degeneration. Therefore, there is a significant interest in new biomarkers useful for the early diagnosis, prognosis, and therapeutic monitoring. In the recent years, protein microarrays have emerged as a powerful proteomic tool to search for new biomarkers. In this study, we have used two concepts for generating protein arrays, antigen microarrays, and NAPPA (nucleic acid programmable protein arrays), to characterize differential autoantibody profiles in a set of 62 samples from OA, rheumatoid arthritis (RA), and healthy controls. An untargeted screen was performed on 3840 protein fragments spotted on planar antigen arrays, and 373 antigens were selected for validation on bead-based arrays. In the NAPPA approach, a targeted screening was performed on 80 preselected proteins. The autoantibody targeting CHST14 was validated by ELISA in the same set of patients. Altogether, nine and seven disease related autoantibody target candidates were identified, and this work demonstrates a combination of these two array concepts for biomarker discovery and their usefulness for characterizing disease-specific autoantibody profiles., We gratefully acknowledge financial support from Euro-TEAM (EU FP7), Knut and Alice Wallenberg Foundation, SciLifeLab Stockholm, the Carlos III Health Institute of Spain (FIS PI11/02114, PI11/02397, PI12/00329; CIBER-CB06/01/0040; RETIC-RIER-RD12/0009/0018), FEDER (European Community), Xunta de Galicia (Red Gallega REDICENT), and Junta Castilla-León SA198A12-2. The Proteomics Unit at CIC belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001.
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Secretome analysis of human articular chondrocytes unravels catabolic effects of nicotine on the joint

  • Lourido Salas, Lucía María
  • Calamia, Valentina
  • Fernández-Puente, Patricia
  • Mateos, Jesús
  • Oreiro Villar, Natividad
  • Blanco García, Francisco J
  • Ruiz-Romero, Cristina
[Abstract] Purpose: Osteoarthritis (OA) is a degenerative joint pathology characterized by articular cartilage degradation that lacks from efficient therapy. Since previous epidemiological data show a high controversy regarding the role of smoking in OA, we aimed to evaluate the effects of nicotine (the most physiologically active compound of tobacco) on the joint. Experimental design: Secretome analyses, based on metabolic labeling followed by LC-MALDI-TOF/TOF analysis, were carried out using an in vitro model of articular inflammation (primary human articular chondrocytes treated with interleukin-1β), and also on osteoarthritic cells. ELISA and Western blot assays were performed to verify some of the results. Results: Nineteen proteins were altered by nicotine in the model of articular inflammation, including several cytokines and proteases. We confirmed the increased secretion by nicotine of matrix metalloproteinase 1 and two proposed markers of OA, fibronectin, and chitinase 3-like protein 1. Finally, four components of the extracellular matrix of cartilage were decreased by nicotine in OA chondrocytes. Conclusions and clinical relevance: Our data contribute to a better understanding of the molecular mechanisms that are modulated by nicotine in cartilage cells, suggesting a negative effect of this drug on the joint., This study was supported by grants from Fondo Investigación Sanitaria-Spain (CP09/00114, PI11/02397, PI12/00329, PI14/01707, CIBER-CB06/01/0040, RETIC-RIER-RD12/0009/0018, and Proteo-Red/ISCIII) and Xunta de Galicia (10CSA916058PR, 10PXIB310153PR, REDICENT and REGICC). L.L. was supported by Xunta de Galicia. C. R.-R. is supported by Fondo Investigación Sanitaria-Spain (Miguel Servet program, CP09/00114).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

The Spanish biology/disease initiative within the human proteome project: application to rheumatic diseases

  • Ruiz-Romero, Cristina
  • Calamia, Valentina
  • Albar, Juan Pablo
  • Casal, José Ignacio
  • Corrales, Fernando J.
  • Fernández-Puente, Patricia
  • Gil, Concha
  • Mateos, Jesús
  • Vivanco, Fernando
  • Blanco García, Francisco J
Review, [Abstract] The Spanish Chromosome 16 consortium is integrated in the global initiative Human Proteome Project, which aims to develop an entire map of the proteins encoded following a gene-centric strategy (C-HPP) in order to make progress in the understanding of human biology in health and disease (B/D-HPP). Chromosome 16 contains many genes encoding proteins involved in the development of a broad range of diseases, which have a significant impact on the health care system. The Spanish HPP consortium has developed a B/D platform with five programs focused on selected medical areas: cancer, obesity, cardiovascular, infectious and rheumatic diseases. Each of these areas has a clinical leader associated to a proteomic investigator with the responsibility to get a comprehensive understanding of the proteins encoded by Chromosome 16 genes. Proteomics strategies have enabled great advances in the area of rheumatic diseases, particularly in osteoarthritis, with studies performed on joint cells, tissues and fluids. Biological significance: In this manuscript we describe how the Spanish HPP-16 consortium has developed a B/D platform with five programs focused on selected medical areas: cancer, obesity, cardiovascular, infectious and rheumatic diseases. Each of these areas has a clinical leader associated to a proteomic investigator with the responsibility to get a comprehensive understanding of the proteins encoded by Chromosome 16 genes. We show how the Proteomic strategy has enabled great advances in the area of rheumatic diseases, particularly in osteoarthritis, with studies performed on joint cells, tissues and fluids. This article is part of a Special Issue entitled: HUPO 2014., This work was funded by grants from Fondo Investigación Sanitaria-Spain (PI11/02397, PI12/00329, CIBER-CB06/01/0040, RETIC-RIER-RD12/0009/0018) and Secretaría I + D + I Xunta de Galicia (10CSA916058PR). J. Mateos (CA11/00050) and P. Fernández-Puente (ProteoRed/ISCIII) are supported by Fondo Investigación Sanitaria-Spain. C. Ruiz-Romero is supported by the Miguel Servet program from Fondo Investigación Sanitaria-Spain (CP09/00114).
RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Characterization of lipidic markers of chondrogenic differentiation using mass spectrometry imaging

  • Rocha Loureda, Beatriz
  • Cillero-Pastor, B.
  • Eijkel, Gert
  • Bruinen, Anne L.
  • Ruiz-Romero, Cristina
  • Heeren, Ron M.A.
  • Blanco García, Francisco J
[Abstract] Mesenchymal stem cells (MSC) are an interesting alternative for cell-based therapy of cartilage defects attributable to their capacity to differentiate toward chondrocytes in the process termed chondrogenesis. The metabolism of lipids has recently been associated with the modulation of chondrogenesis and also with the development of pathologies related to cartilage degeneration. Information about the distribution and modulation of lipids during chondrogenesis could provide a panel of putative chondrogenic markers. Thus, the discovery of new lipid chondrogenic markers could be highly valuable for improving MSC-based cartilage therapies. In this work, MS imaging was used to characterize the spatial distribution of lipids in human bone marrow MSCs during the first steps of chondrogenic differentiation. The analysis of MSC micromasses at days 2 and 14 of chondrogenesis by MALDI-MSI led to the identification of 20 different lipid species, including fatty acids, sphingolipids, and phospholipids. Phosphocholine, several sphingomyelins, and phosphatidylcholines were found to increase during the undifferentiated chondrogenic stage. A particularly detected lipid profile was verified by TOF secondary ion MS. Using this technology, a higher intensity of phosphocholine-related ions was observed in the peripheral region of the micromasses collected at day 14., his work was supported in part through funding from EU COST Action BM1104 (Mass Spectrometry Imaging: new tools for healthcare research), and also from Fondo Investigación Sanitaria, Madrid, Spain (CIBER-CB06/01/0040; PI12/00329; PI11/02397, RETIC-RIER-RD12/0009/0018; Proteo-Red/ISCIII); FEDER (European Community), Xunta de Galicia (Red Gallega REDICENT) and Dutch national program COMMIT.